Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The Role of AI-Generated Clinical Image Descriptions in Enhancing Teledermatology Diagnosis: A Cross-Sectional Exploratory Study
1
Zitationen
9
Autoren
2026
Jahr
Abstract
Background/Objectives: AI models such as ChatGPT-4 have shown strong performance in dermatology; however, the diagnostic value of AI-generated clinical image descriptions remains underexplored. This study assesses whether ChatGPT-4’s image descriptions can support accurate dermatologic diagnosis and evaluates their potential integration into the Electronic Medical Record (EMR) system. Materials & Methods: In this Exploratory cross-sectional study, we analyzed images and descriptions from teledermatology consultations conducted between December 2023 and February 2024. ChatGPT-4 generated clinical descriptions for each image, which two senior dermatologists then used to formulate differential diagnoses. Diagnoses based on ChatGPT-4’s output were compared to those derived from the original clinical notes written by teledermatologists. Concordance was categorized as Top1 (exact match), Top3 (correct within top three), Partial, or No match. Results: The study included 154 image descriptions from 67 male and 87 female patients, aged 0 to 93 years. ChatGPT-4 descriptions averaged 74.3 ± 33.1 words, compared to 7.9 ± 3.0 words for teledermatologists. At least one of the two dermatologists achieved a Top 3 concordance rate of 82.5% using ChatGPT-4’s descriptions and 85.3% with teledermatologist descriptions. Conclusions: Preliminary findings highlight the potential integration of ChatGPT-4-generated descriptions into EMRs to enhance documentation. Although AI descriptions were longer, they did not enhance diagnostic accuracy, and expert validation remained essential.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.581 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.121 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.678 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.825 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.374 Zit.
Autoren
Institutionen
- Rutgers, The State University of New Jersey(US)
- Rambam Health Care Campus(IL)
- Environmental and Occupational Health Sciences Institute(US)
- University of Toronto(CA)
- Emek Medical Center(IL)
- Rappaport Family Institute for Research in the Medical Sciences(IL)
- Ben-Gurion University of the Negev(IL)
- The Technological College of Beer Sheva(IL)
- Tel Aviv University(IL)
- Sheba Medical Center(IL)